Xtandi: Prostate Cancer Drug Approved by FDA

Xtandi: Prostate Cancer Drug Approved By FDA

Filed under: Colorado Drug Treatment Centers

"The need for additional treatment options for advanced prostate cancer continues to be important for patients," Richard Pazdur, director of hematology and oncology products at the FDA's drug evaluation and research center, said in a statement. "Xtandi …
Read more on Huffington Post

Heroin addiction can be blocked: research

Filed under: Colorado Drug Treatment Centers

The new drug automatically shuts this effect down, Hutchinson said. "It really reduces the reward level down to the equivalent of food, sex, and hugs," he told AFP. Professor Linda Watkins, from the Center for Neuroscience at the University of Colorado …
Read more on New York Daily News

Research Predicts Mesothelioma Patients Likely To Benefit From Chemotherapy …

Filed under: Colorado Drug Treatment Centers

A study by researchers at the University of Colorado Cancer Center may help doctors predict which mesothelioma patients will benefit from the chemotherapy drug pemetrexed. Mesothelioma is an aggressive cancer … “The hope is that oncologists could …
Read more on AboutMesothelioma.net

Breast Cancer Drug May Harm the Heart More Than Thought

Filed under: Colorado Drug Treatment Centers

30 (HealthDay News) — Women with breast cancer who are treated with the cancer drug Herceptin may have more long-term cardiac problems than experts have thought, new research suggests. It has been known that … "The early effects of these drugs on …
Read more on Doctors Lounge

FDA Approves Medivation's Prostate Cancer Drug Xtandi
FDA Approves Medivation's Prostate Cancer Drug Xtandi … Read News

New Drug Approved For Late-stage Prostate Cancer
A new drug, Xtandi, has been approved for a type of late-stage prostate cancer. The life-extending drug is taken orally and targets castration-resistant prostate cancer that has spread or recurred. Oregon Health & Science University oversaw trials of the drug. … Read News